Maverick Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-98,098
Closed -$2.41M – 521
2026
Q2
$2.41M Sell
98,098
-46,359
-32% -$1.07M 0.02% 69
2026
Q1
$3.46M Buy
144,457
+37,864
+36% +$926K 0.04% 67
2025
Q4
$2.41M Buy
106,593
+75,278
+240% +$1.64M 0.03% 129
2025
Q3
$631K Buy
+31,315
New +$525K 0.01% 200
2024
Q2
– Sell
-23,813
Closed -$388K – 335
2024
Q1
$388K Buy
+23,813
New +$372K 0.01% 281
2022
Q1
– Sell
-2,329
Closed -$66K – 281
2021
Q4
$66K Sell
2,329
-12,131
-84% -$377K ﹤0.01% 283
2021
Q3
$461K Buy
+14,460
New +$485K ﹤0.01% 445
2021
Q2
– Sell
-1,717,913
Closed -$50.6M – 723
2021
Q1
$50.6M Buy
1,717,913
+1,707,673
+16,676% +$52.5M 0.47% 35
2020
Q4
$314K Buy
+10,240
New +$312K 0.01% 450

Other funds holding ELAN

Maverick Capital's ELAN Position: Q3 2026 in Review

Maverick Capital sold out of Elanco Animal Health (ELAN) in Q3 2026, closing a stake of 98,098 shares — an estimated $2.41M sold.

Maverick Capital first reported a position in ELAN in Q4 2020 and held it in 9 quarters. The position peaked at $50.6M in Q1 2021. 534 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • Maverick Capital reported no remaining Elanco Animal Health position as of Q3 2026 after selling out during the quarter.
  • Maverick Capital sold 98,098 Elanco Animal Health shares in Q3 2026, an estimated $2.41M.
  • Maverick Capital first reported a position in Elanco Animal Health in Q4 2020 and held it in 9 quarters.
  • Maverick Capital's Elanco Animal Health position peaked at $50.6M in Q1 2021.
  • 534 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.